| AWSHX | LGVAX | AWSHX / LGVAX | |
| Total Expense Ratio | 0.55 | 1.01 | 54% |
| Annual Report Gross Expense Ratio | 0.55 | 1.04 | 53% |
| Fund Existence | 74 years | 18 years | - |
| Gain YTD | 6.556 | 15.788 | 42% |
| Front Load | 6% | 6% | 105% |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 218B | 4.32B | 5,050% |
| Annual Yield % from dividends | 1.20 | 1.18 | 102% |
| Returns for 1 year | 7.16 | 12.24 | 59% |
| Returns for 3 years | 33.38 | 20.01 | 167% |
| Returns for 5 years | 28.20 | 4.62 | 611% |
| Returns for 10 years | 78.87 | 71.43 | 110% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GTDIX | 47.45 | N/A | N/A |
| Invesco Emerging Markets ex-China R5 | |||
| BIPSX | 50.09 | N/A | N/A |
| ProFunds Biotechnology UltraSector Svc | |||
| HSRUX | 32.17 | N/A | N/A |
| Carillon Eagle Small Cap Growth R6 | |||
| VSIIX | 59.40 | N/A | N/A |
| Vanguard MStar Small Cap Value Idx Instl | |||
| FVDMX | 46.06 | N/A | N/A |
| Fidelity Advisor Value Discovery C | |||